A citation-based method for searching scientific literature

Shahriar Koochekpour, Sunipa Majumdar, Gissou Azabdaftari, Kristopher Attwood, Ray Scioneaux, Dhatchayini Subramani, Charles Manhardt, Giovanni D Lorusso, Stacey S Willard, Hillary Thompson, Mojgan Shourideh, Katayoon Rezaei, Oliver Sartor, James L Mohler, Robert L Vessella. Clin Cancer Res 2012
Times Cited: 90







List of co-cited articles
770 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.
Cecilia L Speyer, Jennifer S Smith, Malathi Banda, John A DeVries, Tassia Mekani, David H Gorski. Breast Cancer Res Treat 2012
87
21

Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.
Jin Namkoong, Seung-Shick Shin, Hwa Jin Lee, Yarí E Marín, Brian A Wall, James S Goydos, Suzie Chen. Cancer Res 2007
143
18

Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.
Pamela M Pollock, Karine Cohen-Solal, Raman Sood, Jin Namkoong, Jeffrey J Martino, Aruna Koganti, Hua Zhu, Christiane Robbins, Izabela Makalowska, Seung-Shick Shin,[...]. Nat Genet 2003
220
16

Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.
J J Martino, B A Wall, E Mastrantoni, B J Wilimczyk, S N La Cava, K Degenhardt, E White, S Chen. Oncogene 2013
48
31

The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells.
Maithao N Le, Joseph L-K Chan, Stephen A Rosenberg, Adam S Nabatian, Kim T Merrigan, Karine A Cohen-Solal, James S Goydos. J Invest Dermatol 2010
52
23

Expression of glutamate receptor subunits in human cancers.
Andrzej Stepulak, Hella Luksch, Christine Gebhardt, Ortrud Uckermann, Jenny Marzahn, Marco Sifringer, Wojciech Rzeski, Christian Staufner, Katja S Brocke, Lechoslaw Turski,[...]. Histochem Cell Biol 2009
131
13

Glutamate release promotes growth of malignant gliomas.
T Takano, J H Lin, G Arcuino, Q Gao, J Yang, M Nedergaard. Nat Med 2001
388
13

Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies.
Hwa Jin Lee, Brian A Wall, Janet Wangari-Talbot, Seung-Shick Shin, Stephen Rosenberg, Joseph L-K Chan, Jin Namkoong, James S Goydos, Suzie Chen. Clin Cancer Res 2011
56
19

Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice.
Kyu Yeong Choi, Kai Chang, James M Pickel, John D Badger, Katherine W Roche. Proc Natl Acad Sci U S A 2011
67
16

Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma.
Y Ohtani, T Harada, Y Funasaka, K Nakao, C Takahara, M Abdel-Daim, N Sakai, N Saito, C Nishigori, A Aiba. Oncogene 2008
61
18

Molecular pathways: dysregulated glutamatergic signaling pathways in cancer.
Todd D Prickett, Yardena Samuels. Clin Cancer Res 2012
80
13

Cancer cell lines release glutamate into the extracellular environment.
Eric P Seidlitz, Mohit K Sharma, Zeina Saikali, Michelle Ghert, Gurmit Singh. Clin Exp Metastasis 2009
65
15

Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation.
Seung-Shick Shin, Jin Namkoong, Brian A Wall, Ryan Gleason, Hwa Jin Lee, Suzie Chen. Pigment Cell Melanoma Res 2008
65
15


The glutamatergic system expression in human PC-3 and LNCaP prostate cancer cells.
Nikolaos Pissimissis, Efstathia Papageorgiou, Peter Lembessis, Athanasios Armakolas, Michael Koutsilieris. Anticancer Res 2009
41
24

Somatic mutations in GRM1 in cancer alter metabotropic glutamate receptor 1 intracellular localization and signaling.
Jessica L Esseltine, Melinda D Willard, Isabella H Wulur, Mary E Lajiness, Thomas D Barber, Stephen S G Ferguson. Mol Pharmacol 2013
24
41


Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes.
Madhura S Mehta, Sonia C Dolfi, Roman Bronfenbrener, Erhan Bilal, Chunxia Chen, Dirk Moore, Yong Lin, Hussein Rahim, Seena Aisner, Romona D Kersellius,[...]. PLoS One 2013
19
52

On the origin of cancer cells.
O WARBURG. Science 1956
11

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
11

Glutamine addiction: a new therapeutic target in cancer.
David R Wise, Craig B Thompson. Trends Biochem Sci 2010
11

Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.
Todd D Prickett, Xiaomu Wei, Isabel Cardenas-Navia, Jamie K Teer, Jimmy C Lin, Vijay Walia, Jared Gartner, Jiji Jiang, Praveen F Cherukuri, Alfredo Molinolo,[...]. Nat Genet 2011
111
10

Autocrine glutamate signaling promotes glioma cell invasion.
Susan A Lyons, W Joon Chung, Amy K Weaver, Toyin Ogunrinu, Harald Sontheimer. Cancer Res 2007
231
10

Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling.
Alexander Herner, Danguole Sauliunaite, Christoph W Michalski, Mert Erkan, Tiago De Oliveira, Ivane Abiatari, Bo Kong, Irene Esposito, Helmut Friess, Jörg Kleeff. Int J Cancer 2011
66
13

Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells.
Jessica L F Teh, Raj Shah, Stephanie La Cava, Sonia C Dolfi, Madhura S Mehta, Sameera Kongara, Sandy Price, Shridar Ganesan, Kenneth R Reuhl, Kim M Hirshfield,[...]. Breast Cancer Res Treat 2015
20
45

Glutamate enrichment as new diagnostic opportunity in breast cancer.
Jan Budczies, Berit M Pfitzner, Balazs Györffy, Klaus-Jürgen Winzer, Cornelia Radke, Manfred Dietel, Oliver Fiehn, Carsten Denkert. Int J Cancer 2015
78
11

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
Arun Sreekumar, Laila M Poisson, Thekkelnaycke M Rajendiran, Amjad P Khan, Qi Cao, Jindan Yu, Bharathi Laxman, Rohit Mehra, Robert J Lonigro, Yong Li,[...]. Nature 2009
8

A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma.
Dana Yip, Maithao N Le, Joseph L-K Chan, Jonathan H Lee, Janice A Mehnert, Anthony Yudd, Jeffery Kempf, Weichung J Shih, Suzie Chen, James S Goydos. Clin Cancer Res 2009
79
10

AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1).
Seung-Shick Shin, Brian A Wall, James S Goydos, Suzie Chen. Pigment Cell Melanoma Res 2010
37
21

Glutamate receptor ion channels: structure, regulation, and function.
Stephen F Traynelis, Lonnie P Wollmuth, Chris J McBain, Frank S Menniti, Katie M Vance, Kevin K Ogden, Kasper B Hansen, Hongjie Yuan, Scott J Myers, Ray Dingledine. Pharmacol Rev 2010
8

Glutamate receptors in pediatric tumors of the central nervous system.
Katja S Brocke, Christian Staufner, Hella Luksch, Kathrin D Geiger, Andrzej Stepulak, Jenny Marzahn, Gabriele Schackert, Achim Temme, Chrysanthy Ikonomidou. Cancer Biol Ther 2010
47
17

Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.
Jian-Bin Wang, Jon W Erickson, Reina Fuji, Sekar Ramachandran, Ping Gao, Ramani Dinavahi, Kristin F Wilson, Andre L B Ambrosio, Sandra M G Dias, Chi V Dang,[...]. Cancer Cell 2010
580
8

Understanding the Warburg effect: the metabolic requirements of cell proliferation.
Matthew G Vander Heiden, Lewis C Cantley, Craig B Thompson. Science 2009
8

Metabotropic glutamate receptors in cancer.
Lumeng J Yu, Brian A Wall, Janet Wangari-Talbot, Suzie Chen. Neuropharmacology 2017
55
14

From Krebs to clinic: glutamine metabolism to cancer therapy.
Brian J Altman, Zachary E Stine, Chi V Dang. Nat Rev Cancer 2016
854
8

Functional effects of GRM1 suppression in human melanoma cells.
Janet Wangari-Talbot, Brian A Wall, James S Goydos, Suzie Chen. Mol Cancer Res 2012
29
24

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.
Xiaomu Wei, Vijay Walia, Jimmy C Lin, Jamie K Teer, Todd D Prickett, Jared Gartner, Sean Davis, Katherine Stemke-Hale, Michael A Davies, Jeffrey E Gershenwald,[...]. Nat Genet 2011
369
7

Glutamatergic signaling in cellular transformation.
Jessica L F Teh, Suzie Chen. Pigment Cell Melanoma Res 2012
38
18


Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance.
Hee Jin Chang, Byong Chul Yoo, Seok-Byung Lim, Seung-Yong Jeong, Woo Ho Kim, Jae-Gahb Park. Clin Cancer Res 2005
92
7

NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth.
Andrzej Stepulak, Marco Sifringer, Wojciech Rzeski, Stefanie Endesfelder, Alexander Gratopp, Elena E Pohl, Petra Bittigau, Ursula Felderhoff-Mueser, Angela M Kaindl, Christoph Bührer,[...]. Proc Natl Acad Sci U S A 2005
107
7

Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma.
So-Yeon Park, Seoung-Ae Lee, In-Hee Han, Byong-Chul Yoo, Seung-Hoon Lee, Jo-Yong Park, In-Ho Cha, Jin Kim, Sung-Weon Choi. Oncol Rep 2007
47
14

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.
Janice M Mehnert, Ann W Silk, J H Lee, Liesel Dudek, Byeong-Seon Jeong, Jiadong Li, Jason M Schenkel, Evita Sadimin, Michael Kane, Hongxia Lin,[...]. Pigment Cell Melanoma Res 2018
29
24

Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.
Matt I Gross, Susan D Demo, Jennifer B Dennison, Lijing Chen, Tania Chernov-Rogan, Bindu Goyal, Julie R Janes, Guy J Laidig, Evan R Lewis, Jim Li,[...]. Mol Cancer Ther 2014
579
7

Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
Qian Wang, Rae-Anne Hardie, Andrew J Hoy, Michelle van Geldermalsen, Dadi Gao, Ladan Fazli, Martin C Sadowski, Seher Balaban, Mark Schreuder, Rajini Nagarajah,[...]. J Pathol 2015
206
7

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.
Ping Gao, Irina Tchernyshyov, Tsung-Cheng Chang, Yun-Sil Lee, Kayoko Kita, Takafumi Ochi, Karen I Zeller, Angelo M De Marzo, Jennifer E Van Eyk, Joshua T Mendell,[...]. Nature 2009
7

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.
Ralph J DeBerardinis, Anthony Mancuso, Evgueni Daikhin, Ilana Nissim, Marc Yudkoff, Suzanne Wehrli, Craig B Thompson. Proc Natl Acad Sci U S A 2007
7

Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.
Yan Xiang, Zachary E Stine, Jinsong Xia, Yunqi Lu, Roddy S O'Connor, Brian J Altman, Annie L Hsieh, Arvin M Gouw, Ajit G Thomas, Ping Gao,[...]. J Clin Invest 2015
257
7

Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1.
Cecilia L Speyer, Mahdy A Nassar, Ali H Hachem, Miriam A Bukhsh, Waris S Jafry, Rafa M Khansa, David H Gorski. Breast Cancer Res Treat 2016
26
26

Glutamate and its receptors in cancer.
Andrzej Stepulak, Radoslaw Rola, Krzysztof Polberg, Chrysanthy Ikonomidou. J Neural Transm (Vienna) 2014
85
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.